» Articles » PMID: 24852056

Polysubstance Use: Diagnostic Challenges, Patterns of Use and Health

Overview
Specialty Psychiatry
Date 2014 May 24
PMID 24852056
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Polysubstance use is common, particularly amongst some age groups and subcultures. It is also associated with elevated risk of psychiatric and physical health problems. We review the recent research findings, comment on changes to polysubstance diagnoses, report on contemporary clinical and epidemiological polysubstance trends, and examine the efficacy of preventive and treatment approaches.

Recent Findings: Approaches to describing polysubstance use profiles are becoming more sophisticated. Models over the last 18 months that employ latent class analysis typically report a no use or limited-range cluster (alcohol, tobacco and marijuana), a moderate-range cluster (limited range and amphetamine derivatives), and an extended-range cluster (moderate range, and nonmedical use of prescription drugs and other illicit drugs). Prevalence rates vary as a function of the population surveyed. Wide-ranging polysubstance users carry higher risk of comorbid psychopathology, health problems, and deficits in cognitive functioning.

Summary: Wide-ranging polysubstance use is more prevalent in subcultures such as 'ravers' (dance club attendees) and those already dependent on substances. Health risks are elevated in these groups. Research into the prevention and treatment of polysubstance use is underdeveloped. There may be benefit in targeting specific polysubstance use and risk profiles in prevention and clinical research.

Citing Articles

Temporal stability and volatility in population-level high-risk illicit polysubstance use by gender and marital status in the United States, 2002-2019.

England K, Chapman A Soc Sci Med. 2025; 367:117688.

PMID: 39892038 PMC: 11905948. DOI: 10.1016/j.socscimed.2025.117688.


Global screening of health behaviors: Introducing Lev-screening (Lev-s)-development and psychometric evaluation.

Sjowall D, Stalhand F, Schettini G, Gustavsson P, Hirvikoski T PLoS One. 2024; 19(12):e0315565.

PMID: 39724222 PMC: 11670939. DOI: 10.1371/journal.pone.0315565.


The Monitoring Illicit Substance Use Consortium: A Study Protocol.

Greenwood C, Letcher P, Laurance E, Boden J, Foulds J, Spry E JAACAP Open. 2024; 2(4):311-322.

PMID: 39697393 PMC: 11650658. DOI: 10.1016/j.jaacop.2024.03.002.


Study protocol for a randomized controlled trial to adapt a posttraumatic stress disorder intervention of patients with opioid-stimulant polysubstance use receiving methadone maintenance treatment.

Renn T, Griffin B, Kumaravelu V, Ventuneac A, Santacatterina M, Bunting A BMC Psychiatry. 2024; 24(1):879.

PMID: 39627789 PMC: 11616292. DOI: 10.1186/s12888-024-06348-0.


Possible Potentiating Effects of Combined Administration of Alcohol, Caffeine, and Nicotine on In Vivo Dopamine Release in Addiction-Related Circuits Within the CNS of Rats.

Costas-Ferreira C, Barreiro-Chapela M, Duran R, Faro L Biomedicines. 2024; 12(11).

PMID: 39595157 PMC: 11592005. DOI: 10.3390/biomedicines12112591.